Skip to main content
Clinical Trials/NCT02925078
NCT02925078
Completed
Not Applicable

The Influence of Mucosa Tissue Thickness on Marginal Bone Loss of Implants With Smooth Collars: A Prospective Controlled Trial

University of Michigan1 site in 1 country30 target enrollmentNovember 21, 2016
ConditionsGingival Tissue

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gingival Tissue
Sponsor
University of Michigan
Enrollment
30
Locations
1
Primary Endpoint
Radiographic Peri-implant Bone Change (Measured in Millimeters) Between Baseline and 12 Months Follow-up.
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The primary objective of this study is to compare the amount of implant marginal bone loss radiographically and probing depth in between thin and thick mucosa group that will receive a machined collar implant.

Null hypothesis is mucosa thickness does not affect implant marginal bone loss on implant with smooth collar.

Detailed Description

Twenty eight adult patients who fulfill the inclusion criteria will be divided into 2 groups based upon the mucosa thickness (\<2 mm and ≥2 mm). A signed written informed consent will be obtained from all subjects. Subjects will not be screened or treated until an informed consent has been obtained. Patient information will be protected according to the privacy regulations of the federal Health Insurance Portability and Accountability Act of 1996 (HIPAA). The enrolled patients will receive implants with 1 mm polished collar. Implants will be restored at 4 (±1) months after placement. Outcome analyses will be performed until 1 (±1 month) year after loading and clinical and radiographic parameters will be evaluated to compare clinical outcomes between groups. The primary outcome is implant marginal bone loss and probing depth from clinical and radiographic measurements.

Registry
clinicaltrials.gov
Start Date
November 21, 2016
End Date
December 16, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hom-Lay Wang, DDS, MSD, Ph D

Professor of Dentistry and Director of Graduate Periodontics

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • Male or Female
  • In need of one dental implant in the Maxillary or Mandibular area, can be an anterior, premolar, or 1st molar tooth
  • Natural adjacent teeth
  • Bone height of ≥10mm
  • Bone width of ≥5mm
  • Good oral hygiene
  • Stable periodontium
  • Willingness to fulfill all study requirements

Exclusion Criteria

  • Need bone augmentation
  • Need one dental implant that is a 2nd or 3rd molar tooth
  • Current smoker or quit smoking less than one year
  • Pregnant or plan to get pregnant
  • Uncontrolled diabetes (HbA1C \> 7)
  • Medical conditions that may influence the outcome of the study (neurologic or psychiatric disorders, systemic infections )
  • Current use of oral bisphosphonates
  • History of IV bisphosphonates
  • History of radiation therapy in the head and neck area within 4 years
  • Poor oral hygiene (plaque score more than 40% based on O'Leary plaque score)

Outcomes

Primary Outcomes

Radiographic Peri-implant Bone Change (Measured in Millimeters) Between Baseline and 12 Months Follow-up.

Time Frame: 12 months

Radiographic change in remaining bone level (measured in millimeters) between the surgery visit (baseline) and the 12 month follow up visit.

Peri-implant Probing Depth Change (Measured in Millimeters) Between Baseline and 12 Months Follow-up.

Time Frame: 12 months

Change in probing depths (measured in millimeters) around the dental implant between the crown delivery visit and the 12 month follow-up visit.

Study Sites (1)

Loading locations...

Similar Trials